These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27474153)

  • 1. Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs.
    Berte N; Piée-Staffa A; Piecha N; Wang M; Borgmann K; Kaina B; Nikolova T
    Mol Cancer Ther; 2016 Nov; 15(11):2665-2678. PubMed ID: 27474153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rad51 and BRCA2--New molecular targets for sensitizing glioma cells to alkylating anticancer drugs.
    Quiros S; Roos WP; Kaina B
    PLoS One; 2011; 6(11):e27183. PubMed ID: 22073281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroethylnitrosourea-induced cell death and genotoxicity: cell cycle dependence and the role of DNA double-strand breaks, HR and NHEJ.
    Nikolova T; Hennekes F; Bhatti A; Kaina B
    Cell Cycle; 2012 Jul; 11(14):2606-19. PubMed ID: 22751442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling.
    Nikolova T; Roos WP; Krämer OH; Strik HM; Kaina B
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):29-39. PubMed ID: 28143714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
    Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
    Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51.
    Xipell E; Aragón T; Martínez-Velez N; Vera B; Idoate MA; Martínez-Irujo JJ; Garzón AG; Gonzalez-Huarriz M; Acanda AM; Jones C; Lang FF; Fueyo J; Gomez-Manzano C; Alonso MM
    Neuro Oncol; 2016 Aug; 18(8):1109-19. PubMed ID: 26951384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance.
    Krumm A; Barckhausen C; Kücük P; Tomaszowski KH; Loquai C; Fahrer J; Krämer OH; Kaina B; Roos WP
    Cancer Res; 2016 May; 76(10):3067-77. PubMed ID: 26980768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
    Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
    Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mre11/Rad50/Nbs1 complex interacts with the mismatch repair system and contributes to temozolomide-induced G2 arrest and cytotoxicity.
    Mirzoeva OK; Kawaguchi T; Pieper RO
    Mol Cancer Ther; 2006 Nov; 5(11):2757-66. PubMed ID: 17121922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.
    Kaina B; Christmann M; Naumann S; Roos WP
    DNA Repair (Amst); 2007 Aug; 6(8):1079-99. PubMed ID: 17485253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of homologous recombination in human cells by targeting RAD51 recombinase.
    Huang F; Mazina OM; Zentner IJ; Cocklin S; Mazin AV
    J Med Chem; 2012 Apr; 55(7):3011-20. PubMed ID: 22380680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
    Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
    Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
    Eich M; Roos WP; Nikolova T; Kaina B
    Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization matters: nuclear-trapped Survivin sensitizes glioblastoma cells to temozolomide by elevating cellular senescence and impairing homologous recombination.
    Reich TR; Schwarzenbach C; Vilar JB; Unger S; Mühlhäusler F; Nikolova T; Poplawski A; Baymaz HI; Beli P; Christmann M; Tomicic MT
    Cell Mol Life Sci; 2021 Jul; 78(14):5587-5604. PubMed ID: 34100981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the Mre11-Rad50-Nbs1 complex in double-strand break repair-facts and myths.
    Takeda S; Hoa NN; Sasanuma H
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i25-i32. PubMed ID: 27311583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct cellular phenotype linked to defective DNA interstrand crosslink repair and homologous recombination.
    Gorniewska AM; Kluzek K; Gackowska L; Kubiszewska I; Zdzienicka MZ; Bialkowska A
    Mol Med Rep; 2017 Aug; 16(2):1885-1899. PubMed ID: 28627616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycolytic inhibition by 3-bromopyruvate increases the cytotoxic effects of chloroethylnitrosoureas to human glioma cells and the DNA interstrand cross-links formation.
    Sun X; Sun G; Huang Y; Zhang S; Tang X; Zhang N; Zhao L; Zhong R; Peng Y
    Toxicology; 2020 Apr; 435():152413. PubMed ID: 32109525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition.
    Trenner A; Godau J; Sartori AA
    Mol Cancer Ther; 2018 Jul; 17(7):1392-1404. PubMed ID: 29654063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.